The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Aug. 20, 2019
Filed:
Feb. 14, 2017
Applicant:
Cellivery Therapeutics, Inc., Seoul, KR;
Inventor:
Daewoong Jo, Brentwood, TN (US);
Assignee:
CELLIVERY THERAPEUTICS, INC., Seoul, KR;
Attorney:
Primary Examiner:
Int. Cl.
CPC ...
C07K 7/06 (2006.01); C07K 7/08 (2006.01); C07K 14/47 (2006.01); A61K 38/08 (2019.01); A61K 38/10 (2006.01); A61K 38/17 (2006.01); A61K 38/00 (2006.01);
U.S. Cl.
CPC ...
C07K 14/4703 (2013.01); A61K 38/1761 (2013.01); C07K 7/08 (2013.01); A61K 38/00 (2013.01); A61K 38/08 (2013.01); A61K 38/10 (2013.01); A61K 38/1709 (2013.01); C07K 7/06 (2013.01); C07K 14/4702 (2013.01); C07K 2319/01 (2013.01); C07K 2319/10 (2013.01); C07K 2319/21 (2013.01);
Abstract
The present invention relates to providing improved cell-permeable (iCP)-SOCS3 recombinant protein and uses thereof. Preferably, the iCP-SOCS3 recombinant protein may be used as protein-based anti-hepatocellular carcinoma (HCC) agent by utilizing the platform technology for macromolecule intracellular transduction.